| プロジェクト | ステージ | タイプ | 由来 | 疾患領域 | 適応症 |
|---|---|---|---|---|---|
| LIV-1 mAb - 01 | PCC | Monoclonal | Humanized Mouse | Solid Tumor | Colorectal cancer,Breast cancer |
| 英語名 | 研究コード | 研究開発ステージ | 会社 | 適応症 | 臨床試験 |
|---|---|---|---|---|---|
| Ladiratuzumab vedotin | SGN-LIV1A; MK-6440; MK6440 | Phase 2 Clinical | Merck Sharp & Dohme Corp, Seagen Inc | Breast Neoplasms; Carcinoma, Non-Small-Cell Lung; Esophageal Squamous Cell Carcinoma; Gastroesophageal Junction Neoplasms; Melanoma; Metastatic breast cancer; Prostatic Neoplasms; Small Cell Lung Carcinoma; Squamous Cell Carcinoma of Head and Neck; Stomach Neoplasms; Triple Negative Breast Neoplasms | 詳細 |
| Laventatug | BRY-812 | Phase 2 Clinical | Zhejiang BioRay Biopharmaceuticals Co Ltd | Neoplasms; Solid tumours | 詳細 |
